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Abstract 
Purpose: To investigate the effect of the topical decoction of Polygala tenuifolia Willd. and Polygala 
sibirica L. on a guinea pig model of sore and ulcer. 
Method: A guinea pig model of sore and ulcer was produced by Staphylococcus aureus, and 80 guinea 
pigs were evenly divided into eight groups, consisting of five males and five females in each group. 
Another 10 (5 male and 5 female) guinea pigs were used as the control group. The corresponding liquid 
medicine was applied to the ulcer site of the animals in each group, and administered the medicine for 6 
h daily with a continuous applicator for 12 d. Lysozyme content in serum was measured to determine its 
effects on body tissue morphology. 
Results: Compared with the control group, the sore skin score of guinea pigs in each dose group of 
decoction of Polygala tenuifolia Willd. and Polygala sibirica L. was significantly decreased. The skin 
showed apparent positive pathological changes and serum lysozyme concentration increased 
significantly (p < 0.05). 
Conclusion: Decoctions of the two Polygala tenuifolia species exert a good therapeutic effect on the 
guinea pig model of sore and ulcer for topical use. 
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Pyogenic infections are caused by various types 
of pathogenic factors. Ancient physicians believe 
that skin and external diseases are mainly 
caused by Qi-stagnation and blood stasis, 
weakness of Qi and blood, and toxic pathogens 
[1]. There are two sources of Polygala tenuifolia: 
one is the root of Polygala tenufiolia Willd. and 
the other is the root of Polygala sibirica L. 
Polygala tenuifolia has the functions of 
eliminating phlegm, calming the mind, and 
detumescence [2]. It can be used in the 
treatment of hypomnesis caused by heart-kidney 
disharmony, palpitation, sores, and other 
symptoms. Existing research shows that the 
chemical composition of Polygala tenuifolia 
contains saponin [3], which can have the 
functions as antitussives and expectorants, 
sedatives, and anti-aging tonics, and can cure 
sores and swellings [4]. It is recorded in a 
Chinese ancient medical work San Yin Fang that: 
“it is able to cure ulcer, boils, poisoning. Grinding 
Polygala tenuifolia into powders and mixing with 
a small cup of wine can be applied to the 
diseased area”. However, studies of the modern 
clinical use of Polygala tenuifolia are rare. 
Lysozyme which acts exclusively on the B-1,4 
glycosides of peptide [5], can cause cell death. It 
exerts antibacterial and anti-inflammatory effects 
[6]. Jingwanhong ointment, as a compound 
traditional Chinese medicine ointment for an 
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external use, is widely used in the treatment of 
burn and ulcer. As Jingwanhong ointment mainly 
contains Sanguisorba officinalis, Gardenia, 
myrrh, Chinese rhubarb, pangolin, Angelica 
sinensis etc., and it has the function of 
detoxifying and draining pus [7], it is therefore 
widely used in surgery. This paper reported the 
effect of Polygala tenuifolia decoction in external 




Drugs and reagents 
 
Drugs and reagents used were as follows: 
formaldehyde (Yantai Shuangshuang Chemical 
Co., Ltd, batch number: 20100308), 
Jingwanhong (Tianjin Darentang Jingwanhong 
Pharmaceutical Co., Ltd, batch number 211717), 
Staphylococcus aureus (supplied by the 
microbiology laboratory, Henan College of 
Traditional Chinese Medicine), sodium chloride 
injectable solution (Zhengzhou Yonghe 
Pharmaceutical Co., Ltd, batch no. 100422052), 
Qiaomier depilatory cream (Guangzhou Yibai Ya 
Cosmetics Co., Ltd, batch number 20100420), 
and lysozyme test kit (Nanjing Jiancheng 





Polygala tenuifolia Willd. was purchased from 
Jixian County, Tianjin. Polygala sibirica L. was 
obtained from sources in the mountains of 
western Jixian County. Polygala tenuifolia Willd. 
was identified to be the root of Polygala tenufiolia 
Willd. while Polygala sibirica L. is identified as 
the root of Polygala sibirica L. 
 
Polygala decoction was prepared in the following 
procedure: 600 g Polygala tenuifolia Willd. was 
soaked in distilled water (10 times of the 
medicine) for 30 min. Afterwards, the solution 
was simmered for 60 min and then filtered. After 
adding distilled water (eight times of the 
medicine) to simmer the solution for 60 min and 
filter the decoction, the filtrate obtained in the two 
times was merged and heated to 70 °C to further 
concentrate the crude drug content to 1.5, 1, and 
0.5 g/mL. This was followed by high-temperature 
sterilisation and disinfection. The decoction of 





A TDL-40B centrifuge (Shanghai Anting Scientific 
Instrument Factory) and a MJ-180B mould 
incubator (Shanghai Yuejin Medical Instruments 
Factory) were used in the experiment. 
 
S. aureus liquid was cultivated at 37 °C in an 
agar medium for 24 h. Then, sterile sodium 
chloride was injected in the S. aureus bacterial 
colony. The product was ground. In this way, a 
bacterial liquid containing 50 million S. aureus 




In the experiments, 90 guinea pigs (half male 
and half female) weighing 200 ~ 230 g were 
bought from Henan Kangda Laboratory Animal 
Co., Ltd (animal certificate no. 007267). Ethical 
approval was obtained from the Animal 
Experimental Center of Henan University of 
Traditional Chinese Medicine for animal studies 
(approval no. DWLL20130023). The 
experimental animals were treated in accordance 
with the 3R principles (reduction, replacement 
and refinement), proposed by International 




In the experiment, 90 guinea pigs (45 males and 
45 female) weighing 200 - 250 g were used. The 
hair on an area of 3 cm × 3 cm on the right rump 
of the guinea pigs was cut, along with the 
application of a light coating of Qiaomier 
depilatory cream. After 10 min, the depilatory 
cream was washed off with warm water, and the 
guinea pigs did not show obvious damages on 
the skin with hair being removed. One day after 
hair removal, a group of 80 (half male and 
female) guinea pigs were randomly selected, 
with the other 10 guinea pigs forming the control 
group. The guinea pigs were anaesthetised by 
peritoneal injection of 10 % chloral hydrate. 
Then, a cruciate and deep subcutaneous incision 
in a uniform size of 1 cm × 1 cm was produced 
by using a razor blade in the part subjected to 
hair removal. If it bled, the wound was treated 
through press pressure hemostasis using sterile 
cotton. Thereafter, S. aureus bacteria (5 
million/mL, 0.5 mL) was injected in each wound 
with a syringe once a day for three consecutive 
days until mild soreness appeared around the 
wound and purulent secretions were exuded 
from the wound. 
 
Animal grouping and administration 
 
One day after the hair removal, according to the 
principle of each group containing equal number 
of male and female guinea pigs, 80 guinea pigs 
which were established successful models, were 
randomly divided into eight groups: a model 
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group (MG), a group administrated with 
Jingwanhong (Jingwanhong group, Jwh G), 
groups with high, medium, and low-doses of 
Polygala tenuifolia decoction (HD-Polygala 
tenuifolia Willd. DG, MD-Polygala tenuifolia Willd. 
DG, LD-Polygala tenuifolia Willd. DG), and 
groups with high, medium, and low-doses of 
Polygala sibirica L. decoction (HD-Polygala 
sibirica L. DG, MD-Polygala sibirica L. DG, LD-
Polygala sibirica L. DG). Each group contained 
10 guinea pigs (half male and half female). The 
other 10 guinea pigs were included in the control 
group (CG, half male and female).  
 
Corresponding solutions were applied to each 
group with two layers of gauze over the wound. 
To be specific, 0.5 mL 0.9% sodium chloride 
were injected in the MG and CG groups, while 
guinea pigs in Jwh G group were subjected to 
Jingwanhong ointment (0.3 g per animal, 
dressing volume 2 cm × 2 cm × 2 mm). As for the 
groups with high, medium, and low-doses of 
Polygala tenuifolia decoction, they were 
administrated with 0.5 mL corresponding 
decoction (0.75, 0.5, and 0.25 g per animal in 
high, medium, and low-dose groups). The groups 
with high, medium, and low-doses of Polygala 
sibirica L. decoction, were subjected to 0.5 mL of 
corresponding decoction (0.75, 0.5, and 0.25 g 
per animal in high, medium, and low-dose groups 
respectively). The contact time (with the drug) 
was 6 h every day, with continuous coating for 12 
d during administration. To avoid animals licking, 
biting, or nibbling the drugs on the wound, a 
separator was put in their cage. 
 
Determination of detection index  
 
From the first day of treatment, the animals were 
scored every third day to observe wound healing. 
At the 12th d, the guinea pigs were anesthetised 
by 10% chloral hydrate via intraperitoneal 
injected 1 h after the administration. Afterwards, 
chests were opened to expose the hearts. Then, 
a 10 mL syringe was inserted in the hearts to 
extract 5 ~ 8 mL blood specimen via left 
ventricle. The blood specimens were centrifuged 
at 3,000 rpm for 10 min to extract the serum 
according to the instructions in the LZM kit, to 
determine the content of lysozyme therein. The 
wounded skin was cut, fixed with 10% 
formaldehyde solution, subjected to HE staining, 
and observed under a light microscope to detect 
sore skin lesions. 
 
The wound of ulcer skin was judged and scored 
according to the following standard: 
 
0 Point: the ulcer skin was normal; 1 point: the 
ulcer skin was mild redness and swelling, and 
the wound shrank or was healed; 2 point: the 
skin was moderate redness and swelling, and 
there was a scab or a pus scab being found in 
the wound, or a small amount of purulent fluid 
being exuded from the wound; 3 point: the skin 
was serious redness and swelling, and there was 
a scab or a pus scab in the wound, or a small 





The SPSS 14.0 statistical software for Windows 
was used for data analysis. The measurement 
results were expressed as “mean ± standard 
deviation (SD)”. Group comparison was carried 
out using the least using square difference (LSD) 
method. Riddit test showed that the Grade data 
were statistically significant. Differences were 




Effect of the decoction of Polygala tenuifolia 
Willd. and Polygala sibirica L. on ulcer skin 
score 
 
Compared with the control group, at the 3rd, 6th, 
9th, and 12th days, scores of the model group 
were increased significantly (p < 0.01), showing 
that using the method is feasible to prepare sore 
and ulcer models. Compared with the model 
group, until the 9th day, the sore and ulcer skin 
scores in HD-Polygala tenuifolia Willd. DG, MD-
Polygala tenuifolia Willd. DG, and LD- Polygala 
sibirica L. DG were significantly reduced (p < 
0.05); at the 12th day, ulcer score reduced 
significantly in the Jwh group, and in all groups 
with different doses of Polygala tenuifolia Willd. 
and Polygala sibirica L. decoction (p < 0.01, p < 
0.05). The results are shown in Table 1. 
 
Effect of the decoction of Polygala tenuifolia 
Willd. and Polygala sibirica L. on serum 
lysozyme content 
 
Compared with the control group, serum 
lysozyme content of the guinea pigs in the model 
group significantly decreased (p < 0.01), 
indicating that the model was successfully 
replicated. Compared with the model group, 
serum lysozyme content increased significantly 
in the Jwh group, and all groups with different 
doses of Polygala tenuifolia Willd. decoction and 
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Table 1: Effect of Polygala tenuifolia Willd. and Polygala sibirica L. decoction on skin score 
 
Group 3rd day 6th day 9th day 12th day 
CG 0.0±0.0 0.0±0.0 0.0±0.0** 0.0±0.0** 
MG 2.7±0.5** 2.6±0.5** 2.5±0.5 2.1±0.3 
Jwh G 2.5±0.5 2.4±0.5 1.7±0.5** 1.3±0.5** 
HD-Polygala tenuifolia Willd. DG 2.6±0.5 2.5±0.5 1.9±0.6* 1.5±0.5** 
MD-Polygala tenuifolia Willd. DG 2.6±0.5 2.5±0.5 1.9±0.6* 1.5±0.5** 
LD-Polygala tenuifolia Willd. DG 2.6±0.5 2.5±0.5 2.0±0.7 1.5±0.5** 
HD- Polygala sibirica L. DG 2.6±0.5 2.5±0.5 2.0±0.6 1.5±0.5** 
MD- Polygala sibirica L. DG 2.7±0.5 2.6±0.5 2.0±0.7 1.5±0.5** 
LD- Polygala sibirica L. DG 2.6±0.5 2.5±0.5 1.9±0.7* 1.6±0.5* 
Note: Data are relative to those of physiological saline, compared with the model group, * p < 0.05 
and ** p < 0.01 (mean ±SD, n = 10, point) 
Table 2: Effect on serum lysozyme content of 
Polygala tenuifolia and Polygala sibirica L. (mean ± 
SD, n = 10) 
 
Group Serum lysozyme content (µg/ml) 
CG 38.03±5.28 
MG 16.26±4.78** 
Jwh G 25.62±5.62** 
HD-Polygala tenuifolia 
Willd. DG 28.60±6.36** 
MD-Polygala tenuifolia Willd. 
DG 26.75±4.28** 
LD-Polygala tenuifolia Willd. 
DG 26.38±5.75** 
HD- Polygala sibirica L. DG 31.14±5.85** 
MD- Polygala sibirica L. DG 27.18±6.4** 
LD- Polygala sibirica L. DG 27.54±6.98** 
Note: Compared with physiological saline and the 
control group, * p< 0.05 and ** p< 0.01, respectively 
 
Effect of Polygala tenuifolia Willd. and 
Polygala sibirica L. decoction on the 
pathological changes of guinea pig model of 
sore and ulcer 
 
In the control group, subcutaneous tissue, skin 
tissue, and the dorsal squamous epithelium were 
normal (see Plate A in Figure 1). In the model 
group, much accumulation of inflammatory cells 
and abscesses was found in subcutaneous 
tissue, with thickening layers and dorsal 
squamous epithelium (see Plate B in Figure 1). 
In the Jwh group, subcutaneous tissue exhibited 
diffuse infiltration of inflammatory cells and 
multiple small abscesses, accompanying with 
thickening of the back of the keratinised layer 
and squamous epithelial hyperplasia (see Plate 
C in Figure 1). In high doses of the Polygala 
tenuifolia Willd. group, subcutaneous tissue was 
found to show diffuse infiltration of inflammatory 
cells and granulation of tissue, a keratinised 
layer, and normal squamous epithelium of the 
rear (see Plate D in Figure 1). With medium 
doses of Polygala tenuifolia Willd, subcutaneous 
tissue showed much inflammatory cell infiltration 
and granulation of tissue, thickening of the 
keratinised layer, and squamous epithelial 
hyperplasia on the rear (see Plate E in Figure 1). 
With low doses of Polygala tenuifolia Willd., 
subcutaneous tissue showed much inflammatory 
cell infiltration and multiple small abscesses 
formed with thickening of the keratinised layer, 
and squamous epithelial hyperplasia on the rear 
(see Plate F in Figure 1). With high doses of 
Polygala sibirica L., inflammatory cell infiltration 
was found to be scattered in the subcutaneous 
tissue, and show granulation of tissue, thickening 
of the keratinised layer, and squamous epithelial 
hyperplasia on the rear (see Plate G, Figure 1). 
With medium doses of Polygala sibirica L., 
subcutaneous tissue showed multiple small 
abscesses and granulation of tissue, the 
keratinised layer was normal, as the dorsal 
squamous epithelial hyperplasia (see Plate H, 
Figure 1). With low doses of Polygala sibirica L., 
subcutaneous tissue presented diffuse 
inflammatory cell infiltration and granulation of 
tissue, thickening keratinised layer, and 
squamous epithelial hyperplasia on the rear (see 
Plate I, Figure 1). 
 
Through pathological observation, compared with 
the control group, the model group showed more 
serious pathological injury (p < 0.01), indicating 
that the sore and ulcer model was successfully 
established. Compared with the model group, 
groups with every dose of Polygala tenuifolia 
Willd. and Polygala sibirica L., and the Jwh group 
showed significant reduction in the ulceration 
while the guinea pigs underwent pathological 
changes (p < 0.01). The results indicated that the 
decoction of Polygala tenuifolia Willd. and 
Polygala sibirica L. contribute to heal ulcers in 
guinea pigs (see Table 3). 
 
In Table 3, “-” indicates that the back, the skin of 
the epidermis, and the subcutaneous tissue 
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presented normal squamous epithelium. “+” 
refers to that the back and the skin of the 
epidermis had normal squamous epithelium and 
a small amount of inflammatory cell infiltration 
was seen in the subcutaneous tissue. “++” 
means that the squamous epithelium of the back 
and the hyperplasia of the skin of the epidermis 
were normal and subcutaneous tissue showed a 
significant inflammatory cell infiltration and little 
scattering thereof. “+++” shows that the 
squamous epithelium of the back and the skin 
layer was significantly thickened, and a 
significant amount of inflammatory cell infiltration 
was seen with the formation of larger abscesses 




Figure 1: Pathological changes in guinea pigs (HE × 100) A: CG; B; MG; C: Jwh G; D: HD-Polygala 
tenuifolia Willd. DG; E: MD-Polygala tenuifolia Willd. DG; F: LD-Polygala tenuifolia Willd. DG; G: HD-
Polygala sibirica L. DG; H: MD-Polygala sibirica L. DG; I: LD-Polygala sibirica L. DG 
 
Table 3: Effect on the pathological changes of guinea pigs model of sore and ulcer (mean ± SD, n = 10) 
 
Group - + ++ +++ P-value 
CG 10 0 0 0  
MG 0 0 1 9 ** 
Jwh G 0 3 5 2 ** 
HD-Polygala tenuifolia Willd. DG 4 3 3 0 ** 
MD-Polygala tenuifolia Willd. DG 2 4 4 0 ** 
LD-Polygala tenuifolia Willd. DG 0 2 7 1 ** 
HD- Polygala sibirica L. DG 9 1 0 0 ** 
MD- Polygala sibirica L. DG 4 2 4 0 ** 
LD- Polygala sibirica L. DG 4 4 2 0 ** 
Note: Compared with physiological saline and the model group, *p < 0.05, **p < 0.01 separately 
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Sore and ulcer are mainly caused by Qi 
stagnation, stagnation of Ying-qi, and meridian 
obstruction [9]. Wound infection, ulcer formation, 
pain in the skin, and shallow wound infections 
are called abscesses. Sore and ulcer are skin 
diseases whose wound is found within the 
muscles, and the purulent blood stasis is serious 
after being infected, accompanied by swelling, 
heat, and pain in the skin [10]. Lysozyme, as one 
of the non-specific immune factors in human 
body [11], can relax bacterial cell wall which 
therefore cannot protect the cell, causing final 
cell death [12].  
 
By observing the content of lysozyme in serum, it 
can more favourably reflect the antibacterial and 
anti-phlogistic effects of the drug. Therefore, 
content of lysozyme can be used as a depth 
index for determining the healing degree of ulcer. 
After skin ulcer occurs, marking scores for the 
wound can help to judge the development 
degree of ulcer and the improvement of the 
pathological changes can better reflect the sore 
from the microscopic aspect.  
 
By generating skin injury artificially in guinea pigs 
through Staphylococcus aureus infection, this 
research established the guinea pig model of 
sore and ulcer. Results revealed that the 
modelling method was reasonable. Wound 
tenderness, purulent secretions, redness, pain, 
heat, and swelling were seen 2 days after the 
infection [13].  
 
The experimental results showed that every dose 
used in Polygala tenuifolia Willd. and Polygala 
sibirica L. groups significantly reduced the skin 
ulcer score of guinea pigs and significantly 
increased serum lysozyme content of the 
pyocutaneous model therein. At the same time, 
the drugs significantly reduced pathological 
changes in the guinea pigs. The results showed 
that the two Polygala tenuifolia species have a 
treatment effect on sore and ulcer of guinea pigs, 




The findings of this study show that Polygala 
tenuifolia Willd. and Polygala sibirica L. can 
promote wound healing improve serum lysozyme 
levels. These two species are sources of 
Polygala tenuifolia included in the 2010 Chinese 
Pharmacopoeia [14], and demonstrate good 
therapeutic effects on the guinea pig model of 
sore and ulcer. Further studies are, however, 






This study was supported by National "11th Five-
Year" Support Program (no. 2008BAI53B09); 
University Science and Technology Innovation 
Team (no. 2012IRTSTHN011); and Zhengzhou 
Science and Technology Innovation Team Project 
(no. 131PCXTD612). Besides, the authors would 
like to thank Ruiqin Li, Professor of Pathology, 
Henan University of Traditional Chinese 
Medicine for assisting with the pathology studies. 
 
Conflict of Interest 
 
No conflict of interest associated with this work. 
 
Contribution of Authors 
 
The authors declare that this work was done by 
 the authors named in this article and all liabilities 
pertaining to claims relating to the content of this 
article will be borne by them. 
 
Open Access  
 
This is an Open Access article that uses a 
funding model which does not charge readers or 
their institutions for access and distributed under 
the terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by 
/4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/rea
d), which permit unrestricted use, distribution, 
and reproduction in any medium, provided the 




1. Yue JH, Zhang QH, Sun ZR. The status quo and analysis 
of clinical studies of Chinese medicine for the external 
treatment of sores. J External Therapy Tradit Chinese 
Med 2013; 22(4): 55-56. 
2. Dong XB, Li J, Zheng Y. Preparation of tenuifolin from 
radix polygalae as a reference substance. Tradit 
Chinese Drug Res Clin Pharmaco 2007; 18(1): 53-54. 
3. Lin JK, Yan XP, Guan SJ, Li L. A study of the saponin 
content of different processed products of radix 
polygalae. Chinese J Exp Tradit Med Form 2011; 
17(11): 89-91. 
4. Du FL, Wang J. Research progress of Polygala. 
Huazhang 2012; (28): 319-320. 
5. Dong AX, Wang Q, Fan XR, Wang P, Cui L, Yuan JG, 
Zhang JF. Immobilisation of lysozyme catalyzed by 
laccase on bast fabrics and its antibacterial properties. J 
Funct Mater 2014; 2(45): 02044-02048. 
Miao et al 
Trop J Pharm Res, January 2017; 16(1): 81  
 
6. He JH, Liu Y, Liu GJ, Li LN, Li HC, Wang LJ. Application 
of, and research progress in, lysozyme in medicine. 
Prog Pharm Sci 2008; 18(2): 16-19. 
7. Zhang SC, Guo DL, Liu WW, et al. Clinical application 
development of Jingwanhong Ointment. J Pharm Res, 
2014, 33(12): 718-720. 
8. Qv YQ, Ha HX, Guo YQ, et al. Application of 3R principle 
in medical animal experimental work. Laboratory Animal 
Science, 2010, 27(6): 84-85. 
9. Zhang GY, Li XJ. Overview of the study on the treatment 
of sores with external Chinese medicine. Glob Tradit 
Chinese Med 2010; 3(2): 101-106. 
10. Tang PP, Guo XF, Bai Ming, Miao MS. Effect of 
Ampelopsis external application on a sores/ulcers 
model. China J Tradit Chinese Med Pharm 2012; 27(3): 
702-705. 
11. Tang SW. Research progress in the comprehensive 
application of egg shell and egg white. Shanghai J Anim 
Husband Vet Med 2014; 1: 20-22. 
12. Zhang P, Jiang MF, Wang Y. Research progress of 
lysozyme from animal source. China J Biol Engrng, 
2012, 32 (08): 87-93. 
13. Yu SY, Miao MS. Effects of external application of 
physalis on sores and ulcers in a rats and guinea pigs. 
China J Tradit Chinese Med Pharm 2014; 29(2): 611-
614. 
14. Liu YL, Wang YY, Zeng K. Hole identification of Polygala 
tenuifolia Willd. and Polygala. J Chinese Med, 2014, 29 
(10): 1473-1476. 
 
